Frequency and prognostic value of resistance/intolerance to hydroxycarbamide in 890 patients with polycythaemia vera.
about
From leeches to personalized medicine: evolving concepts in the management of polycythemia vera.Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyurea.Therapy of polycythemia vera: is it time to change?Ruxolitinib is effective and safe in Japanese patients with hydroxyurea-resistant or hydroxyurea-intolerant polycythemia vera with splenomegaly.Ruxolitinib for the treatment of inadequately controlled polycythemia vera without splenomegaly: 80-week follow-up from the RESPONSE-2 trial
P2860
Frequency and prognostic value of resistance/intolerance to hydroxycarbamide in 890 patients with polycythaemia vera.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Frequency and prognostic value ...... ients with polycythaemia vera.
@en
Frequency and prognostic value ...... ients with polycythaemia vera.
@nl
type
label
Frequency and prognostic value ...... ients with polycythaemia vera.
@en
Frequency and prognostic value ...... ients with polycythaemia vera.
@nl
prefLabel
Frequency and prognostic value ...... ients with polycythaemia vera.
@en
Frequency and prognostic value ...... ients with polycythaemia vera.
@nl
P2093
P2860
P50
P356
P1476
Frequency and prognostic value ...... tients with polycythaemia vera
@en
P2093
Abelardo Bárez
Alberto Alvarez-Larrán
Ana Kerguelen
Carles Besses
Carmen Burgaleta
Gonzalo Caballero
Grupo Español de Enfermedades Mieloproliferativas Filadelfia Negativas (GEMFIN)
M Antonia Durán
M Isabel Mata
Manuel Pérez-Encinas
P2860
P304
P356
10.1111/BJH.13886
P407
P50
P577
2015-12-21T00:00:00Z